Trial Profile
Study of CGS 20267 [letrozole] in pre- and postmenopausal women with metastatic cancer
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Nov 2005
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 27 Nov 2005 New trial record.